Rennova Health, Inc. (RNVA)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2022 | -3.29 Million USD | 73.47% |
| 2021 | -12.34 Million USD | 30.05% |
| 2020 | -17.64 Million USD | 70.8% |
| 2019 | -60.42 Million USD | -330.91% |
| 2018 | -14.02 Million USD | 74.6% |
| 2017 | -55.19 Million USD | -69.25% |
| 2016 | -32.61 Million USD | 6.1% |
| 2015 | -34.73 Million USD | -572.55% |
| 2014 | -5.16 Million USD | -55.82% |
| 2013 | -3.31 Million USD | 15.63% |
| 2012 | -3.92 Million USD | -174.88% |
| 2011 | -1.42 Million USD | 54.35% |
| 2010 | -3.13 Million USD | 83.05% |
| 2009 | -18.46 Million USD | -133.73% |
| 2008 | -7.9 Million USD | -143.65% |
| 2007 | 18.1 Million USD | 237.02% |
| 2006 | -13.21 Million USD | -48.8% |
| 2005 | -8.88 Million USD | 42.2% |
| 2004 | -15.36 Million USD | -21.91% |
| 2003 | -12.6 Million USD | 0.18% |
| 2002 | -12.62 Million USD | -44.62% |
| 2001 | -8.73 Million USD | -1348.93% |
| 2000 | 699 Thousand USD | 105.56% |
| 1999 | -12.57 Million USD | 16.75% |
| 1998 | -15.1 Million USD | -174.55% |
| 1997 | -5.5 Million USD | -277.42% |
| 1996 | 3.1 Million USD | -44.64% |
| 1995 | 5.6 Million USD | 600.0% |
| 1994 | 800 Thousand USD | 153.33% |
| 1993 | -1.5 Million USD | -198.68% |
| 1992 | 1.52 Million USD | 2271.43% |
| 1991 | -70 Thousand USD | 99.19% |
| 1990 | -8.64 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 Q1 | 805.56 Thousand USD | -3.09% |
| 2023 Q2 | 1.27 Million USD | 58.63% |
| 2023 Q3 | -548.22 Thousand USD | -142.9% |
| 2022 FY | -3.27 Million USD | 73.47% |
| 2022 Q3 | -1.28 Million USD | 99.34% |
| 2022 Q4 | 831.25 Thousand USD | 164.9% |
| 2022 Q2 | -195.45 Million USD | -41.08% |
| 2022 Q1 | -138.53 Million USD | -15239.87% |
| 2021 Q4 | -903.13 Thousand USD | -167.86% |
| 2021 FY | -12.34 Million USD | 30.05% |
| 2021 Q3 | 1.33 Million USD | -85.33% |
| 2021 Q1 | -3.89 Million USD | 54.07% |
| 2021 Q2 | 9.07 Million USD | 332.96% |
| 2020 FY | -17.64 Million USD | 70.8% |
| 2020 Q1 | -5.79 Million USD | 34.94% |
| 2020 Q2 | 2.12 Million USD | 136.63% |
| 2020 Q3 | -6.19 Million USD | -391.85% |
| 2020 Q4 | -8.47 Million USD | -36.91% |
| 2019 Q1 | -13.44 Million USD | -32.14% |
| 2019 Q2 | -13.42 Million USD | 0.12% |
| 2019 Q3 | -12.26 Million USD | 8.63% |
| 2019 Q4 | -8.9 Million USD | 27.43% |
| 2019 FY | -60.42 Million USD | -330.91% |
| 2018 FY | -14.02 Million USD | 74.6% |
| 2018 Q1 | -146.36 Million USD | -509.2% |
| 2018 Q4 | -10.17 Million USD | -112.84% |
| 2018 Q3 | 79.25 Million USD | 74.88% |
| 2018 Q2 | 45.31 Million USD | 130.96% |
| 2017 Q2 | -10.67 Million USD | 78.52% |
| 2017 Q3 | -10.82 Million USD | -1.38% |
| 2017 Q4 | -24.02 Million USD | -121.94% |
| 2017 Q1 | -49.7 Million USD | -373.46% |
| 2017 FY | -55.19 Million USD | -69.25% |
| 2016 FY | -32.61 Million USD | 6.1% |
| 2016 Q1 | -4.24 Million USD | 86.53% |
| 2016 Q2 | -5.86 Million USD | -38.13% |
| 2016 Q3 | -12 Million USD | -104.87% |
| 2016 Q4 | -10.49 Million USD | 12.58% |
| 2015 Q2 | -1.34 Million USD | 24.27% |
| 2015 Q3 | -956 Thousand USD | 28.92% |
| 2015 FY | -34.73 Million USD | -572.55% |
| 2015 Q1 | -1.77 Million USD | -58.01% |
| 2015 Q4 | -31.5 Million USD | -3195.11% |
| 2014 Q2 | -1.24 Million USD | -31.23% |
| 2014 Q1 | -951 Thousand USD | 5.28% |
| 2014 Q4 | -1.12 Million USD | -10.63% |
| 2014 Q3 | -1.01 Million USD | 18.59% |
| 2014 FY | -5.16 Million USD | -55.82% |
| 2013 Q4 | -1 Million USD | -78.33% |
| 2013 Q3 | -563 Thousand USD | 29.36% |
| 2013 Q2 | -797 Thousand USD | 1.73% |
| 2013 Q1 | -811 Thousand USD | 29.6% |
| 2013 FY | -3.31 Million USD | 15.63% |
| 2012 Q1 | -2.22 Million USD | -198.15% |
| 2012 FY | -3.92 Million USD | -174.88% |
| 2012 Q2 | -679 Thousand USD | 69.51% |
| 2012 Q3 | -1.28 Million USD | -89.1% |
| 2012 Q4 | -1.15 Million USD | 10.28% |
| 2011 Q4 | 2.26 Million USD | 576.68% |
| 2011 FY | -1.42 Million USD | 54.35% |
| 2011 Q3 | -476 Thousand USD | 52.11% |
| 2011 Q2 | -994 Thousand USD | -41.19% |
| 2011 Q1 | -704 Thousand USD | -665.22% |
| 2010 Q1 | -5.39 Million USD | 38.56% |
| 2010 Q2 | -2.46 Million USD | 54.25% |
| 2010 Q3 | 134 Thousand USD | 105.43% |
| 2010 Q4 | -92 Thousand USD | -168.66% |
| 2010 FY | -3.13 Million USD | 83.05% |
| 2009 Q1 | -3.24 Million USD | -137.88% |
| 2009 Q4 | -8.77 Million USD | -419.78% |
| 2009 FY | -18.46 Million USD | -133.73% |
| 2009 Q2 | -2.6 Million USD | 19.71% |
| 2009 Q3 | -1.68 Million USD | 35.21% |
| 2008 Q1 | 15.21 Million USD | 436.91% |
| 2008 FY | -7.9 Million USD | -143.65% |
| 2008 Q3 | -2.49 Million USD | -215.53% |
| 2008 Q4 | -1.36 Million USD | 45.38% |
| 2008 Q2 | -792 Thousand USD | -105.21% |
| 2007 Q2 | -638 Thousand USD | 68.18% |
| 2007 Q1 | -2 Million USD | 67.27% |
| 2007 FY | 18.1 Million USD | 237.02% |
| 2007 Q4 | 2.83 Million USD | 308.95% |
| 2007 Q3 | 693 Thousand USD | 208.62% |
| 2006 Q2 | -1.8 Million USD | -0.78% |
| 2006 Q1 | -1.78 Million USD | 6.09% |
| 2006 FY | -13.21 Million USD | -48.8% |
| 2006 Q4 | -6.12 Million USD | -86.68% |
| 2006 Q3 | -3.28 Million USD | -82.08% |
| 2005 Q2 | -2.5 Million USD | 34.87% |
| 2005 FY | -8.88 Million USD | 42.2% |
| 2005 Q1 | -3.84 Million USD | -43.19% |
| 2005 Q4 | -1.9 Million USD | 28.98% |
| 2005 Q3 | -2.68 Million USD | -6.94% |
| 2004 Q2 | -6.32 Million USD | -109.58% |
| 2004 Q3 | -2.5 Million USD | 60.46% |
| 2004 FY | -15.36 Million USD | -21.91% |
| 2004 Q4 | -2.68 Million USD | -7.48% |
| 2004 Q1 | -3.01 Million USD | 54.69% |
| 2003 Q4 | -6.66 Million USD | -298.86% |
| 2003 Q2 | -1.25 Million USD | 26.02% |
| 2003 Q1 | -1.69 Million USD | 48.04% |
| 2003 FY | -12.6 Million USD | 0.18% |
| 2003 Q3 | -1.67 Million USD | -33.17% |
| 2002 Q4 | -3.26 Million USD | 32.35% |
| 2002 FY | -12.62 Million USD | -44.62% |
| 2002 Q3 | -4.82 Million USD | -69.43% |
| 2002 Q2 | -2.84 Million USD | -132.33% |
| 2002 Q1 | -1.22 Million USD | 51.81% |
| 2001 Q2 | -2.49 Million USD | 42.7% |
| 2001 Q4 | -2.54 Million USD | -3.0% |
| 2001 Q3 | -2.46 Million USD | 1.08% |
| 2001 Q1 | -4.35 Million USD | -160.63% |
| 2001 FY | -8.73 Million USD | -1348.93% |
| 2000 Q3 | 162 Thousand USD | 107.07% |
| 2000 FY | 699 Thousand USD | 105.56% |
| 2000 Q4 | 7.18 Million USD | 4332.72% |
| 2000 Q1 | -1.87 Million USD | 35.48% |
| 2000 Q2 | -2.29 Million USD | -22.39% |
| 1999 Q1 | -4.7 Million USD | -20.51% |
| 1999 FY | -12.57 Million USD | 16.75% |
| 1999 Q4 | -2.9 Million USD | 27.5% |
| 1999 Q3 | -4 Million USD | -5.26% |
| 1999 Q2 | -3.8 Million USD | 19.15% |
| 1998 Q1 | -2 Million USD | -66.67% |
| 1998 Q4 | -3.9 Million USD | -25.81% |
| 1998 Q3 | -3.1 Million USD | 8.82% |
| 1998 Q2 | -3.4 Million USD | -70.0% |
| 1998 FY | -15.1 Million USD | -174.55% |
| 1997 Q2 | -1.2 Million USD | -400.0% |
| 1997 Q3 | -1.1 Million USD | 8.33% |
| 1997 Q4 | -1.2 Million USD | -9.09% |
| 1997 FY | -5.5 Million USD | -277.42% |
| 1997 Q1 | 400 Thousand USD | -20.0% |
| 1996 FY | 3.1 Million USD | -44.64% |
| 1996 Q3 | 400 Thousand USD | -76.47% |
| 1996 Q4 | 500 Thousand USD | 25.0% |
| 1996 Q1 | 2 Million USD | 33.33% |
| 1996 Q2 | 1.7 Million USD | -15.0% |
| 1995 FY | 5.6 Million USD | 600.0% |
| 1995 Q4 | 1.5 Million USD | 36.36% |
| 1995 Q2 | 1 Million USD | 66.67% |
| 1995 Q3 | 1.1 Million USD | 10.0% |
| 1995 Q1 | 600 Thousand USD | 200.0% |
| 1994 FY | 800 Thousand USD | 153.33% |
| 1994 Q4 | 200 Thousand USD | 0.0% |
| 1994 Q3 | - USD | 100.0% |
| 1994 Q2 | -100 Thousand USD | 0.0% |
| 1993 FY | -1.5 Million USD | -198.68% |
| 1992 FY | 1.52 Million USD | 2271.43% |
| 1991 FY | -70 Thousand USD | 99.19% |
| 1990 FY | -8.64 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| American Bio Medica Corporation | -1.41 Million USD | -133.55% |
| Arrayit Corporation | -3.31 Million USD | 0.68% |
| Atlantic International Corp. | -5.62 Million USD | 41.484% |
| Biocept, Inc. | -32.08 Million USD | 89.737% |
| Bioqual, Inc. | 483.48 Thousand USD | 781.114% |
| CardioGenics Holdings Inc | -1.91 Million USD | -71.842% |
| DermTech, Inc. | -100.88 Million USD | 96.736% |
| Global WholeHealth Partners Corporation | - USD | Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 2.02 Billion USD | 100.163% |
| HTG Molecular Diagnostics, Inc. | -21.59 Million USD | 84.75% |
| iMD Companies, Inc. | -200.63 Thousand USD | -1541.308% |
| IDenta Corp. | 14.64 Thousand USD | 22587.401% |
| Interpace Biosciences, Inc. | 802 Thousand USD | 510.605% |
| Integrative Health Technologies, Inc. | 38.68 Thousand USD | 8611.605% |
| InVitro International | 1553.00 USD | 212144.752% |
| Lumos Diagnostics Holdings Limited | -8.59 Million USD | 61.673% |
| Many Bright Ideas Technologies Inc. | -58.11 Thousand USD | -5566.738% |
| Medical Imaging Corp. | -3.02 Million USD | -8.932% |
| NovelStem International Corp. | -4.18 Million USD | 21.356% |
| Optigenex Inc. | -2.89 Million USD | -13.641% |
| PharmChem, Inc. | 845.1 Thousand USD | 489.664% |
| Proteome Sciences plc | -2.44 Million USD | -34.796% |
| Response Genetics, Inc | -20.18 Million USD | 83.685% |
| RushNet, Inc. | -607.02 Thousand USD | -442.488% |
| ScreenPro Security Inc. | -2.24 Million USD | -46.438% |
| Stella Diagnostics Inc. | -5.7 Million USD | 42.302% |
| StageZero Life Sciences Ltd. | -11.41 Million USD | 71.152% |
| Todos Medical Ltd. | -24.99 Million USD | 86.825% |